MICHAEL A DAVIES to Imatinib Mesylate
This is a "connection" page, showing publications MICHAEL A DAVIES has written about Imatinib Mesylate.
Connection Strength
0.062
-
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates. Mol Cancer Ther. 2009 Aug; 8(8):2079-85.
Score: 0.062
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.